[{"AccountsPayableCurrent_0_Q1_USD":1102815.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":66400.0,"OperatingLeaseLeaseIncome_1_Q1_USD":4900.0,"IncreaseDecreaseInOtherReceivables_1_Q1_USD":7529.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":null,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":1158400.0,"OperatingLeaseExpense_1_Q1_USD":41600.0,"NotesPayable_0_Q1_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":114600.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":333432.0,"ProceedsFromIssuanceOfWarrants_1_Q1_USD":null,"OtherAssetsNoncurrent_0_Q1_USD":25000.0,"NonoperatingIncomeExpense_1_Q1_USD":-698878.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":116000.0,"EmployeeBenefitsAndShareBasedCompensation_1_Q1_USD":1500000.0,"PrepaidExpenseCurrent_0_Q1_USD":246007.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":130400.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":16700.0,"PaymentsForProceedsFromInvestments_1_Q1_USD":-13598416.0,"PrepaidInsurance_0_Q1_USD":102400.0,"InterestIncomeExpenseNet_1_Q1_USD":407652.0,"PaymentsToAcquireInvestments_1_Q1_USD":37230631.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther_1_Q1_shares":1155086.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_1_Q1_USD":0.0,"OtherShortTermInvestments_0_Q1_USD":102690508.0,"LeaseIncentiveReceivableNoncurrent_0_Q1_USD":146588.0,"LeaseIncentiveReceivableCurrent_0_Q1_USD":74633.0,"IncreaseDecreaseInLeasingReceivables_1_Q1_USD":-17704.0,"ContractualObligationDueInSecondYear_0_Q1_USD":null,"ContractualObligationDueAfterFifthYear_0_Q1_USD":null,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-177855.0,"ContractualObligation_0_Q1_USD":122590.0,"AccruedBonusesCurrentAndNoncurrent_0_Q1_USD":273300.0,"PrepaidExpenseCurrentAndNoncurrent_0_Q1_USD":246000.0,"OtherReceivablesNetCurrent_0_Q1_USD":7529.0,"SettlementLiabilitiesCurrent_0_Q1_USD":null,"ProceedsFromRepaymentsOfNotesPayable_1_Q1_USD":-110247.0,"ContractualObligationDueInNextTwelveMonths_0_Q1_USD":122590.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5039400.0,"ShortTermInvestments_0_Q1_USD":102690508.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q1_USD":5039362.0,"UnrealizedGainLossOnDerivatives_1_Q1_USD":-934919.0,"IncomeTaxesPaid_1_Q1_USD":null,"AccruedVacationCurrent_0_Q1_USD":204100.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-23632215.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":3004946.0,"LiabilitiesCurrent_0_Q1_USD":2261183.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":115420716.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":580153.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5466654.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.72,"Depreciation_1_Q1_USD":1046.0,"CommonStockValue_0_Q1_USD":14941.0,"CommonStockSharesOutstanding_0_Q1_shares":14940668.0,"CommonStockSharesIssued_0_Q1_shares":14940668.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-24052032.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":12226487.0,"AssetsCurrent_0_Q1_USD":115245164.0,"Assets_0_Q1_USD":115420716.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7158571.0,"AdditionalPaidInCapital_0_Q1_USD":243676817.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3424763.0,"NetIncomeLoss_1_Q1_USD":-10673316.0,"ProfitLoss_1_Q1_USD":-10673316.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3964.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3115193.0,"ShareBasedCompensation_1_Q1_USD":5039362.0,"ResearchAndDevelopmentExpense_1_Q1_USD":4507784.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":null,"PreferredStockSharesIssued_0_Q1_shares":null,"PreferredStockSharesAuthorized_0_Q1_shares":200000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":12700.0,"OperatingIncomeLoss_1_Q1_USD":-9974438.0,"NotesPayableCurrent_0_Q1_USD":null,"InterestPaidNet_1_Q1_USD":2415.0,"CommonStockSharesAuthorized_0_Q1_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AccruedLiabilitiesCurrent_0_Q1_USD":1158368.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":14738230.0,"StockholdersEquity_0_Q1_USD":113159533.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-130532225.0,"OperatingExpenses_1_Q1_USD":9974438.0,"UnrealizedLossOnSecurities_1_Q1_USD":934919.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200515"}]